Alpha fetoprotein levels in neonatal hyperbilirubinaemia

Area of Science:

• Neonatalogy
• Biochemistry
• Pediatrics

Background:

• Neonatal hyperbilirubinemia, or jaundice, is common in newborns.
• Alpha fetoprotein (AFP) is a protein primarily produced during fetal development.

Purpose of the Study:

• To investigate serum alpha fetoprotein (AFP) levels in neonatally hyperbilirubinaemic infants compared to controls.
• To determine the relationship between serum bilirubin and AFP concentrations in hyperbilirubinaemic infants.

Main Methods:

• A case-control study involving 15 hyperbilirubinaemic neonates and 15 matched controls.
• Serum AFP levels were measured at 5-7 days, 20-25 days, and 40-49 days postnatally.

Main Results:

• Hyperbilirubinaemic infants showed significantly higher serum AFP concentrations than controls across all measured time points (p < 0.001).
• Mean serum AFP levels in hyperbilirubinaemic infants were more than double those of controls during the first seven weeks of life.
• No significant correlation was observed between serum bilirubin and AFP levels within the hyperbilirubinaemic group.

Conclusions:

• Neonatal hyperbilirubinemia is associated with transiently elevated serum AFP levels.
• Elevated AFP levels normalize by seven weeks postpartum, suggesting a temporary physiological response.
• The study did not find a direct correlation between the severity of jaundice and AFP levels.